Results from Multi-Center Study Support the Application of Minimally Invasive Treatment for Broader BPH Population WAYNE, Pa. – July... Read More
The UroLift® System for the treatment of Benign Prostatic Hyperplasia (BPH) was the subject of three presentations at the Glasgow,... Read More
PLEASANTON, Calif. – December 14, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet... Read More
A new Government scheme announced today selects the UroLift® System as one of seven innovations across all specialisms that are... Read More
WAYNE, PA – June 08, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet... Read More
PLEASANTON, Calif. – May 16, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet... Read More
PLEASANTON, Calif. and Boston – May 15, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs... Read More
PLEASANTON, Calif. and LONDON – March 27, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs... Read More
PLEASANTON, CA, US March 23, 2017 – NeoTract, Inc., announced today that the largest private health insurer in Ireland, Vhi... Read More
LONDON –The UroLift System treatment for enlarged prostate has been highlighted as a strategically important product for the future of... Read More
US
AU
UK